{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:15:09Z","timestamp":1767842109877,"version":"3.49.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1097\/med.0b013e328358be97","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T16:02:04Z","timestamp":1377878524000},"page":"460-467","source":"Crossref","is-referenced-by-count":28,"title":["Hypophosphatemic rickets"],"prefix":"10.1097","volume":"19","author":[{"given":"Giampiero I.","family":"Baroncelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetta","family":"Toschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvano","family":"Bertelloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20211004","first-page":"529","article-title":"Rickets resistant to vitamin D therapy.","volume":"54","author":"Albright","year":"1937","journal-title":"Am J Dis Child"},{"key":"R2-5-20211004","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/en.2010-0800","article-title":"Minireview: fibroblast growth factor 23 in phosphate homeostasis and bone metabolism.","volume":"152","author":"Hori","year":"2011","journal-title":"Endocrinology"},{"key":"R3-5-20211004","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00774-011-0298-0","article-title":"Fibroblast growth factor 23 as a phosphotropic hormone and beyond.","volume":"29","author":"Fukumoto","year":"2011","journal-title":"J Bone Miner Metab"},{"issue":"Suppl 121","key":"R4-5-20211004","first-page":"1","article-title":"Phosphate and FGF-23.","volume":"79","author":"Juppner","year":"2011","journal-title":"Kidney Int"},{"key":"R5-5-20211004","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00002.2011","article-title":"Regulation and function of the FGF23Klotho endocrine pathways.","volume":"92","author":"Martin","year":"2012","journal-title":"Physiol Rev"},{"key":"R6-5-20211004","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bone.2012.01.010","article-title":"Tooth dentin defects reflect genetic disorders affecting bone mineralization.","volume":"50","author":"Opsahl Vital","year":"2012","journal-title":"Bone"},{"key":"R7-5-20211004","doi-asserted-by":"crossref","first-page":"E1492","DOI":"10.1210\/jc.2012-1336","article-title":"Abnormalities in muscle density and muscle function in hypophosphatemic rickets.","volume":"97","author":"Veilleux","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-5-20211004","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00431-010-1382-5","article-title":"Fibroblast growth factor (FGF)23: a new hormone.","volume":"170","author":"Alon","year":"2011","journal-title":"Eur J Pediatr"},{"key":"R9-5-20211004","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00467-012-2103-2","article-title":"Genetic disorders of phosphate regulation.","volume":"27","author":"Gattineni","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R10-5-20211004","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bone.2011.06.029","article-title":"A patient with hypophosphatemic rickets and ossification of posterior longitudinal ligament caused by a novel homozygous mutation in ENPP1 gene.","volume":"49","author":"Saito","year":"2011","journal-title":"Bone"},{"key":"R11-5-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00774-011-0340-2","article-title":"The expanding family of hypophosphatemic syndromes.","volume":"30","author":"Carpenter","year":"2012","journal-title":"J Bone Miner Metab"},{"key":"R12-5-20211004","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/rheumatology\/kes089","article-title":"Novel compound heterozygous mutations in ENPP1 cause hypophosphataemic rickets with anterior spinal ligament ossification.","volume":"51","author":"Mehta","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R13-5-20211004","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/EJE-12-0071","article-title":"Mutational analysis of patients with FGF23-related hypophosphatemic rickets.","volume":"167","author":"Kinoshita","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"R14-5-20211004","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/jhg.2012.56","article-title":"Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets.","volume":"57","author":"Beck-Nielsen","year":"2012","journal-title":"J Hum Gen"},{"key":"R15-5-20211004","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.bone.2012.02.015","article-title":"Novel NaPi-IIc mutations causing HHRH and idiopathic hypercalciuria in several unrelated families: long-term follow-up in one kindred.","volume":"50","author":"Yu","year":"2012","journal-title":"Bone"},{"key":"R16-5-20211004","doi-asserted-by":"crossref","first-page":"C1316","DOI":"10.1152\/ajpcell.00314.2011","article-title":"Processing and stability of type IIc sodium-dependent phosphate cotransporter mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria.","volume":"302","author":"Haito-Sugino","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"R17-5-20211004","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4274\/jcrpe.601","article-title":"SLC34A3 intronic deletion in a new kindred with hereditary hypophosphatemic rickets with hypercalciuria.","volume":"4","author":"Hasani-Ranjbar","year":"2012","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"R18-5-20211004","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00467-010-1657-0","article-title":"Dents disease: clinical features and molecular basis.","volume":"26","author":"Claverie-Martin","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"R19-5-20211004","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.ajkd.2011.08.035","article-title":"Evaluation of hypophosphatemia: lessons from patients with genetic disorders.","volume":"59","author":"Bacchetta","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R20-5-20211004","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1073\/pnas.0712361105","article-title":"A translocation causing increased -Klotho level results in hypophosphatemic rickets and hyperparathyroidism.","volume":"105","author":"Brownstein","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"R21-5-20211004","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00223-011-9501-5","article-title":"Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3. E1 cell proliferation and inhibit mineralization.","volume":"89","author":"Shalhoub","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"R22-5-20211004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2011.08.030","article-title":"Vitamin D metabolism in the kidney: regulation by phosphorus and fibroblast growth factor 23.","volume":"347","author":"Perwad","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"R23-5-20211004","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nm0411-428","article-title":"Dem bones are made for more than walking.","volume":"17","author":"Quarles","year":"2011","journal-title":"Nat Med"},{"key":"R24-5-20211004","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/j.ajkd.2010.12.027","article-title":"Role of Klotho in aging, phosphate metabolism, and CKD.","volume":"58","author":"John","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R25-5-20211004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4614-0887-1_3","article-title":"FGF23 and syndromes of abnormal renal phosphate handling.","volume":"728","author":"Bergwitz","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"R26-5-20211004","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMra0904186","article-title":"Genetic disorders of renal phosphate transport.","volume":"362","author":"Prie","year":"2010","journal-title":"N Engl J Med"},{"issue":"Suppl 121","key":"R27-5-20211004","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/ki.2011.26","article-title":"Phosphate and klotho.","volume":"79","author":"Kuro-O","year":"2011","journal-title":"Kidney Int"},{"key":"R28-5-20211004","first-page":"84","article-title":"FGF23, klotho and vitamin D interactions: what have we learned from in vivo mouse genetics studies Adv Exp Med B","volume":"728","author":"Razzaque","year":"2012","journal-title":"iol"},{"key":"R29-5-20211004","doi-asserted-by":"crossref","first-page":"F783","DOI":"10.1152\/ajprenal.00304.2010","article-title":"ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate.","volume":"300","author":"David","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"R30-5-20211004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1615\/CritRevEukarGeneExpr.v22.i1.50","article-title":"Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.","volume":"22","author":"Rowe","year":"2012","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"R31-5-20211004","doi-asserted-by":"crossref","first-page":"e1002708","DOI":"10.1371\/journal.pgen.1002708","article-title":"Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice.","volume":"8","author":"Wang","year":"2012","journal-title":"PLoS Genet"},{"key":"R32-5-20211004","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","article-title":"Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice.","volume":"108","author":"Farrow","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R33-5-20211004","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1210\/jc.2011-1239","article-title":"Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans.","volume":"96","author":"Imel","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R34-5-20211004","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bone.2011.10.009","article-title":"Follow-up study of Gambian children with rickets-like bone deformities and elevated plasma FGF23: possible aetiological factors.","volume":"50","author":"Braithwaite","year":"2012","journal-title":"Bone"},{"key":"R35-5-20211004","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.bone.2012.03.010","article-title":"Iron status and fibroblast growth factor-23 in Gambian children.","volume":"50","author":"Braithwaite","year":"2012","journal-title":"Bone"},{"key":"R36-5-20211004","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1507\/endocrj.K10E-257","article-title":"High iFGF23 level despite hypophosphatemia is one of theclinical indicators to make diagnosis of XLH.","volume":"58","author":"Igaki","year":"2011","journal-title":"Endocr J"},{"key":"R37-5-20211004","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1210\/jc.2009-1671","article-title":"Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations.","volume":"95","author":"Imel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R38-5-20211004","first-page":"266","article-title":"Tertiary hyperparathyroidism in a patient with X-linked hypophosphatemic rickets.","volume":"11","author":"Tournis","year":"2011","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"R39-5-20211004","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2350-12-116","article-title":"Genetic diagnosis of X-linked dominant hypophosphatemic rickets in a cohort study: tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation type.","volume":"12","author":"Morey","year":"2011","journal-title":"BMC Med Genet"},{"key":"R40-5-20211004","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinicians guide to X-linked hypophosphatemia.","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Min Res"},{"key":"R41-5-20211004","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00467-011-2046-z","article-title":"Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment.","volume":"27","author":"Quinlan","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R42-5-20211004","doi-asserted-by":"crossref","first-page":"E2097","DOI":"10.1210\/jc.2011-0399","article-title":"Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion.","volume":"96","author":"Zivicnjak","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R43-5-20211004","first-page":"359","article-title":"Growth hormone treatment in a child with X-linked hypophosphataemic rickets.","volume":"67","author":"Prasad","year":"2011","journal-title":"MJAFI"},{"key":"R44-5-20211004","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1056\/NEJMc1010928","article-title":"Calcitonin administration in X-linked hypophosphatemia.","volume":"364","author":"Liu","year":"2011","journal-title":"N Engl J Med"},{"key":"R45-5-20211004","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jbmr.275","article-title":"Anti-FGF-23 neutralizing antibodies ameliorate muscle weakness and decreased spontaneous movement of Hyp Mice.","volume":"26","author":"Aono","year":"2011","journal-title":"J Bone Miner Res"},{"key":"R46-5-20211004","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/978-1-4614-0887-1_10","article-title":"FGF23 as a novel therapeutic target.","volume":"728","author":"Shimada","year":"2012","journal-title":"Adv Exp Med Biol"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201212000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T02:18:44Z","timestamp":1633313924000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201212000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e328358be97","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}